231 related articles for article (PubMed ID: 38114719)
21. Treatment Options and Goals for Patients with Generalized Pustular Psoriasis.
Krueger J; Puig L; Thaçi D
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):51-64. PubMed ID: 35061230
[TBL] [Abstract][Full Text] [Related]
22. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
Menter A; Van Voorhees AS; Hsu S
Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
[TBL] [Abstract][Full Text] [Related]
23. Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment.
Rivera-Díaz R; Daudén E; Carrascosa JM; Cueva P; Puig L
Dermatol Ther (Heidelb); 2023 Mar; 13(3):673-688. PubMed ID: 36635445
[TBL] [Abstract][Full Text] [Related]
24. Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?
Megna M; Camela E; Ruggiero A; Battista T; Martora F; Cacciapuoti S; Potestio L
Clin Cosmet Investig Dermatol; 2023; 16():1677-1690. PubMed ID: 37404368
[TBL] [Abstract][Full Text] [Related]
25. Current management of generalized pustular psoriasis.
Kodali N; Blanchard I; Kunamneni S; Lebwohl MG
Exp Dermatol; 2023 Aug; 32(8):1204-1218. PubMed ID: 36779681
[TBL] [Abstract][Full Text] [Related]
26. Exploring the Quality-of-Life Impact, Disease Burden, and Management Challenges of GPP: The Provider and Patient Perspective [Podcast].
Hawkes JE; Reisner DV; Bhutani T
Clin Cosmet Investig Dermatol; 2023; 16():3333-3339. PubMed ID: 38021429
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis of Generalized Pustular Psoriasis.
Fujita H; Gooderham M; Romiti R
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):31-38. PubMed ID: 35061226
[TBL] [Abstract][Full Text] [Related]
28. Clinical Course and Characteristics of Generalized Pustular Psoriasis.
Choon SE; Navarini AA; Pinter A
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):21-29. PubMed ID: 35061227
[TBL] [Abstract][Full Text] [Related]
29. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion.
Bachelez H; Barker J; Burden AD; Navarini AA; Krueger JG
Expert Rev Clin Immunol; 2022 Oct; 18(10):1033-1047. PubMed ID: 36062811
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial.
Tsai TF; Zheng M; Ding Y; Song Z; Liu Q; Chen Y; Hu H; Xu J
Dermatol Ther (Heidelb); 2023 Dec; 13(12):3097-3110. PubMed ID: 37840119
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of recalcitrant generalized pustular psoriasis of pregnancy with spesolimab.
Yang C; Wang Y; Li R; Tu P; Wang R
J Dermatolog Treat; 2024 Dec; 35(1):2334791. PubMed ID: 38565205
[TBL] [Abstract][Full Text] [Related]
32. Clinical Disease Measures in Generalized Pustular Psoriasis.
Burden AD; Choon SE; Gottlieb AB; Navarini AA; Warren RB
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):39-50. PubMed ID: 35061231
[TBL] [Abstract][Full Text] [Related]
33. An update on generalized pustular psoriasis.
Gooderham MJ; Van Voorhees AS; Lebwohl MG
Expert Rev Clin Immunol; 2019 Sep; 15(9):907-919. PubMed ID: 31486687
[No Abstract] [Full Text] [Related]
34. Exploring the Clinical Presentation, Course, and Burden of Disease in Generalized Pustular Psoriasis [Podcast].
Merola JF; Amin AZ
Clin Cosmet Investig Dermatol; 2024; 17():539-545. PubMed ID: 38482176
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiology of Generalized Pustular Psoriasis.
Marrakchi S; Puig L
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):13-19. PubMed ID: 35061228
[TBL] [Abstract][Full Text] [Related]
36. Generalized pustular psoriasis: practical recommendations for Spanish primary care and emergency physicians.
Rivera-Diaz R; Epelde F; Heras-Hitos JA; Martínez Virto AM; Dávalos Marin AJ; Senán Sanz MR; Carrascosa JM
Postgrad Med; 2023 Nov; 135(8):766-774. PubMed ID: 38019177
[TBL] [Abstract][Full Text] [Related]
37. A review of disease burden and clinical management for generalized pustular psoriasis in China.
Lu J; Shi Y
Expert Rev Clin Immunol; 2022 Oct; 18(10):1023-1032. PubMed ID: 36040447
[TBL] [Abstract][Full Text] [Related]
38. Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study.
Navarini AA; Prinz JC; Morita A; Tsai TF; Viguier MA; Li L; Thoma C; Sivalingam M; Lebwohl MG
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):730-736. PubMed ID: 36527385
[TBL] [Abstract][Full Text] [Related]
39. Spesolimab: First Approval.
Blair HA
Drugs; 2022 Nov; 82(17):1681-1686. PubMed ID: 36418672
[TBL] [Abstract][Full Text] [Related]
40. Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists.
Strober B; Kotowsky N; Medeiros R; Mackey RH; Harrold LR; Valdecantos WC; Flack M; Golembesky AK; Lebwohl M
Dermatol Ther (Heidelb); 2021 Apr; 11(2):529-541. PubMed ID: 33638115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
